Valters Bolevics

Valters Bolevics
Valters is Director General of the International Research-Based Pharmaceutical Manufacturers Association of Latvia (SIFFA). His responsibilities include the development, management and coordination of government affairs strategies related to national legislation, programs and institutions. His role also includes the development of strategies to address the regulatory and policy environment in Latvia to better facilitate the objectives of the association’s members and create a positive presence among state and national parliamentarians, members of the government, civil servants, and the various affiliated agencies. Valters is an internationally experienced management consultant with more than 15 years of experience in the government sectors, strategic communication, …
Valters is Director General of the International Research-Based Pharmaceutical Manufacturers Association of Latvia (SIFFA).

His responsibilities include the development, management and coordination of government affairs strategies related to national legislation, programs and institutions. His role also includes the development of strategies to address the regulatory and policy environment in Latvia to better facilitate the objectives of the association’s members and create a positive presence among state and national parliamentarians, members of the government, civil servants, and the various affiliated agencies.

Valters is an internationally experienced management consultant with more than 15 years of experience in the government sectors, strategic communication, public affairs and public policy.

Valters holds a PhD in management science and has been involved in numerous advisory projects across the Middle East and Europe.
See more

Articles: Valters Bolevics

Breakthroughs in Latvia, with More Innovative Drugs than Ever Before

Latvia / Latvia has seen some major breakthroughs in recent years: more innovative medicines are available to patients than ever before; the market for commercial, OTC and reimbursable medicinal products has achieved new heights, and we are in a strong position to continue this trend. What has been accomplished and what challenges is Latvia facing today with…

Latvia: Striving to Catch Up to its Neighbours on Innovation Access

Latvia / Dr Valters Bolevics, director general of the Association of International Research-based Pharmaceuticals Manufacturers of Latvia (SIFFA), outlines the progress made on market access for innovative pharmaceuticals in Latvia in recent years and the hurdles still to be overcome to catch up with its Baltic neighbours.   Stable pharmaceutical product market growth, the biggest state funding…

Recent Developments in Latvian Pharma

Opinion / Dr Valters Bolevics, CEO of the Association of International Research-based Pharmaceutical Manufacturers (SIFFA) in Latvia, gives an overview of recent market changes affecting the Latvian pharmaceutical market, regulatory upgrades, and growth projections for 2020.   Following a breakthrough year in 2018, 2019 has also seen numerous positive changes for the innovative pharmaceutical industry in Latvia.…

See more